Antineuronal antibodies in Parkinson's disease

Movement Disorders

Volumn 23, Issue 7, 2008, Pages 958-963

  van de Warrenburg, Bart P C ^a,b   Church, Andrew J ^a   Martino, Davide ^a,c   Candler, Paul M ^a   Bhatia, Kailash P ^a   Giovannoni, Gavin ^d   Quinn, Niall P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BARI   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antineuronal ganglia antibodies; Inflammation; Parkinson's disease

Indexed keywords

ANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; NEURON SPECIFIC ENOLASE; NEURONAL ANTIBODY; PYRUVATE KINASE; UNCLASSIFIED DRUG; ANTIGEN; CARRIER PROTEIN; ENOLASE; MEMBRANE PROTEIN; THYROID HORMONE; THYROID HORMONE BINDING PROTEINS; THYROID HORMONE-BINDING PROTEINS;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENETIC DISORDER; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; WESTERN BLOTTING; BASAL GANGLION; CEREBELLUM; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES; ANTIGENS; BASAL GANGLIA; BLOTTING, WESTERN; CARRIER PROTEINS; CEREBELLUM; FEMALE; HUMANS; INFLAMMATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEURONS; PARKINSON DISEASE; PHOSPHOPYRUVATE HYDRATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID HORMONES;

EID: 49249115031     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21929     Document Type: Article

References (22)

1. Klein C. Implications of genetics on the diagnosis and care of patients with Parkinson disease. Arch Neurol 2006;63:328-334.
2. Calne DB, Langston JW. Aetiology of Parkinson's disease. Lancet 1983;2:1457-1459.
3. Church AJ, Cardoso F, Dale RC, et al. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002; 59:227-231.
4. Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003;9:914-920.
5. Dale RC, Church AJ, Surtees RA, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004;127:21-33.
6. Rizzo R, Gulisano M, Pavone P, et al. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 2006;21:747-753.
7. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271.
8. Dale RC, Candler PM, Church AJ, et al. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2006;172:187-197.
9. Kansy JW, Katsovich L, McIver KS, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 2006;181:165-176.
10. Edwards MJ, Dale RC, Church AJ, et al. Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies. Mov Disord 2004;19:1190-1196.
11. Edwards MJ, Trikouli E, Martino D, et al. Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study. Neurology 2004;63:156-158.
12. Giovannoni G. Anti-neuronal antibodies and movement disorders. J Neuroimmunol 2005;163:5-7.
13. Singer HS, Hong JJ, Rippel CA, et al. The need for caution in considering the diagnostic utility of antibasal ganglia antibodies in movement disorders. Arch Dis Child 2004;89:595-597.
14. Hovsepyan MR, Haas MJ, Boyajyan AS, et al. Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus. Neurosci Lett 2004;369:224-227.
15. Maruyama I, Maeda T, Okisaka S, et al. Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo. Jpn J Ophthalmol 2002;46:1-12.
16. Ben-Pazi H, Livne A, Shapira Y, et al. Parkinsonian features after streptococcal pharyngitis. J Pediatr 2003;143:267-269.
17. Abramsky O, Litvin Y. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspect Biol Med 1978;22:104-114.
18. Barker RA, Cahn AP. Parkinson's disease: an autoimmune process. Int J Neurosci 1988;43:1-7.
19. Dahlstrom A, Wigander A, Lundmark K, et al. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J Neural Transm SuppI 1990;29:195-206.
20. Orr CF, Rowe DB, Mizuno Y, et al. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 2005; 128:2665-2674.
21. Bulliard C, Zurbriggen R, Tornare J, et al. Purification of a dichlorophenol-indophenol oxidoreductase from rat and bovine synaptic membranes: tight complex association of a glyceraidehyde-3-phosphate dehydrogenase isoform, TOAD64, enolase-gamma and aldolase C Biochem J 1997;324:555-563.
22. Nagata K, Nakajima K, Kohsaka S. Plasminogen promotes the development of rat mesencephalic dopaminergic neurons in vitro. Brain Res Dev Brain Res 1993;75:31-37.